130 related articles for article (PubMed ID: 23734690)
1. Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever.
Vänskä M; Purhonen AK; Koivula I; Jantunen E; Hämäläinen S; Pulkki K; Juutilainen A
Leuk Lymphoma; 2014 Mar; 55(3):718-21. PubMed ID: 23734690
[No Abstract] [Full Text] [Related]
2. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
[TBL] [Abstract][Full Text] [Related]
4. Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies.
Jansen RR; Biemond BJ; Schinkel J; Koekkoek SM; Molenkamp R; de Jong MD; Visser CE
Virol J; 2013 Jun; 10():212. PubMed ID: 23805898
[TBL] [Abstract][Full Text] [Related]
5. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
6. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
7. What's new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates?
Rieger C; Barlow S; Maschmeyer G
Intensive Care Med; 2014 Oct; 40(10):1549-52. PubMed ID: 24972884
[No Abstract] [Full Text] [Related]
8. Febrile neutropenia in hematologic malignancies.
Keng MK; Sekeres MA
Curr Hematol Malig Rep; 2013 Dec; 8(4):370-8. PubMed ID: 23990311
[TBL] [Abstract][Full Text] [Related]
9. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
[TBL] [Abstract][Full Text] [Related]
10. Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.
Richter ME; Neugebauer S; Engelmann F; Hagel S; Ludewig K; La Rosée P; Sayer HG; Hochhaus A; von Lilienfeld-Toal M; Bretschneider T; Pausch C; Engel C; Brunkhorst FM; Kiehntopf M
Infection; 2016 Apr; 44(2):175-86. PubMed ID: 26275448
[TBL] [Abstract][Full Text] [Related]
11. Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia.
Reers Y; Idelevich EA; Pätkau H; Sauerland MC; Tafelski S; Nachtigall I; Berdel WE; Peters G; Silling G; Becker K;
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):413-5. PubMed ID: 27220608
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever.
Yilmaz G; Mentese A; Kaya S; Uzun A; Karahan SC; Koksal I
J Clin Virol; 2011 Mar; 50(3):209-11. PubMed ID: 21167774
[TBL] [Abstract][Full Text] [Related]
13. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
[TBL] [Abstract][Full Text] [Related]
14. From lactate to soluble urokinase plasminogen activator receptor: The journey for ideal cardiac biomarker: Are we there in 2016?
Kapoor PM
Ann Card Anaesth; 2016; 19(2):211-3. PubMed ID: 27052058
[No Abstract] [Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening.
Kjellman A; Akre O; Gustafsson O; Høyer-Hansen G; Lilja H; Norming U; Piironen T; Törnblom M
J Intern Med; 2011 Mar; 269(3):299-305. PubMed ID: 21138491
[TBL] [Abstract][Full Text] [Related]
16. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
[TBL] [Abstract][Full Text] [Related]
17. SuPAR, an emerging biomarker in kidney and inflammatory diseases.
Hamie L; Daoud G; Nemer G; Nammour T; El Chediak A; Uthman IW; Kibbi AG; Eid A; Kurban M
Postgrad Med J; 2018 Sep; 94(1115):517-524. PubMed ID: 30177549
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
19. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
